Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: coment

  1. Aomar-Millán, I.F.
  2. Salvatierra, J.
  3. Callejas-Rubio, J.L.
  4. Raya-Álvarez, E.
Aldizkaria:
Reumatologia Clinica

ISSN: 1885-1398,  1699-258X

Argitalpen urtea: 2023

Alea: 19

Zenbakia: 2

Orrialdeak: 120-121

Mota: Gutuna

DOI: 10.1016/J.REUMA.2022.01.003 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus